AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33509703 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 0
Study 33509703 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care basal insulin (SOC-BI)
Number of subjects: 0
Study 36315954 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombectomy alone
Number of subjects: 0
Study 36315954 — intervention group
Group type: COMPARATOR
Intervention: Alteplase + thrombectomy
Number of subjects: 0
Study 36215911 — intervention group
Group type: EXPERIMENTAL
Intervention: Video observation of methadone take-home dosing
Number of subjects: 44
Study 36215911 — intervention group
Group type: EXPERIMENTAL
Intervention: Full pilot program participants
Number of subjects: 44
Study 36215911 — intervention group
Group type: EXPERIMENTAL
Intervention: Full pilot participants
Number of subjects: 44
Study 36215911 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 44
Study 36215911 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical outcomes
Number of subjects: 44
Study 33634446 — intervention group
Group type: EXPERIMENTAL
Intervention: Restarting oral anticoagulation within 14 days
Number of subjects: 352
Study 33634446 — intervention group
Group type: EXPERIMENTAL
Intervention: Restarting oral anticoagulation
Number of subjects: 352
Study 32778158 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 94
Study 32778158 — intervention group
Group type: COMPARATOR
Intervention: Sham Electroacupuncture (sham EA)
Number of subjects: 94
Study 34133836 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil plus SULT1A1 enzyme booster
Number of subjects: 24
Study 34133836 — intervention group
Group type: COMPARATOR
Intervention: 5% topical minoxidil plus placebo adjuvant
Number of subjects: 24
Study 33838094 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massage with lavender essential oil
Number of subjects: 105
Study 33838094 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massage with orange essential oil
Number of subjects: 105
Study 33838094 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 105
Study 36150553 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental impact labels only
Number of subjects: 2730
Study 36150553 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental impact labels with nutrition labels
Number of subjects: 2730
Study 36150553 — intervention group
Group type: COMPARATOR
Intervention: Nutrition labels only
Number of subjects: 2730
Study 36150553 — intervention group
Group type: COMPARATOR
Intervention: Both environmental and nutrition labels
Number of subjects: 2730
Study 36150553 — intervention group
Group type: COMPARATOR
Intervention: No labels (control)
Number of subjects: 2730
Study 33393617 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted mode method
Number of subjects: 0
Study 33393617 — intervention group
Group type: EXPERIMENTAL
Intervention: MRMix method
Number of subjects: 0
Study 33393617 — intervention group
Group type: EXPERIMENTAL
Intervention: Random-effect IVW method
Number of subjects: 0
Study 33393617 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-Robust method
Number of subjects: 0
Study 33393617 — intervention group
Group type: EXPERIMENTAL
Intervention: MR-RAPS method
Number of subjects: 0
Study 33393617 — intervention group
Group type: EXPERIMENTAL
Intervention: Various MR methods
Number of subjects: 0
Study 33393617 — intervention group
Group type: EXPERIMENTAL
Intervention: Down-sampling analysis
Number of subjects: 0
Study 33573276 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of Pera orange juice
Number of subjects: 0
Study 33573276 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of Moro orange juice
Number of subjects: 0
Study 33573276 — intervention group
Group type: EXPERIMENTAL
Intervention: Profile B individuals (stratified group)
Number of subjects: 0
Study 33573276 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratification based on metabolic profiles
Number of subjects: 0
Study 32539157 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention plus referral to treatment
Number of subjects: 126
Study 32539157 — intervention group
Group type: COMPARATOR
Intervention: Referral to treatment only
Number of subjects: 126
Study 36347056 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrase strand transfer inhibitor therapy
Number of subjects: 0
Study 36347056 — intervention group
Group type: EXPERIMENTAL
Intervention: Single high-dose liposomal amphotericin
Number of subjects: 0
Study 36347056 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryptococcal antigen lateral flow assay
Number of subjects: 0
Study 36347056 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic inflammation, astrocyte activation, and tryptophan metabolism pathways
Number of subjects: 0
Study 34850013 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted resting heart rate (10 beat/min higher)
Number of subjects: 878663
Study 34850013 — intervention group
Group type: COMPARATOR
Intervention: Higher genetically predicted systolic blood pressure (SBP), TG, glucose, and WHR
Number of subjects: 878663
Study 34850013 — intervention group
Group type: COMPARATOR
Intervention: Lower high-density lipoprotein
Number of subjects: 878663
Study 32015185 — intervention group
Group type: EXPERIMENTAL
Intervention: P6 acupressure
Number of subjects: 120
Study 32015185 — intervention group
Group type: EXPERIMENTAL
Intervention: LI4 acupressure
Number of subjects: 120
Study 32015185 — intervention group
Group type: COMPARATOR
Intervention: Control (thumb pad pressure)
Number of subjects: 120
Study 34489282 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced informed consent (experimental arm) - includes full length trial PIS, a two-page study aid, and 10 online educational videos.
Number of subjects: 34
Study 34489282 — intervention group
Group type: COMPARATOR
Intervention: Standard informed consent (control arm) - includes full length trial PIS and administration of QuIC-A and QuIC-B.
Number of subjects: 34
Study 33303437 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 3922
Study 33303437 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 3922
Study 35269639 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg daily gluten intake
Number of subjects: 0
Study 35269639 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34231257 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoas muscle area (PMA) measurement before liver transplantation (LT)
Number of subjects: 276
Study 32215562 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week outreach rehabilitation program
Number of subjects: 77
Study 32215562 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 77
Study 33939730 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) - 3 X 5 min at 50 mmHg above systolic blood pressure
Number of subjects: 9
Study 33939730 — intervention group
Group type: COMPARATOR
Intervention: SHAM intervention - same as IPC but at 20 mmHg
Number of subjects: 9
Study 33183258 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous TXA (1.0 g by intravenous injection before tourniquet inflation and before surgical incision closure)
Number of subjects: 0
Study 33183258 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TXA (3.0 g in 75 mL physiological saline 5 min prior to final tourniquet release)
Number of subjects: 0
Study 33183258 — intervention group
Group type: COMPARATOR
Intervention: Placebo (physiological saline solution)
Number of subjects: 0
Study 35878827 — intervention group
Group type: EXPERIMENTAL
Intervention: Mothers and Babies 1‐on‐1 delivered by lay home visitors
Number of subjects: 1229
Study 35878827 — intervention group
Group type: COMPARATOR
Intervention: Usual home visiting services
Number of subjects: 1229
Study 33830339 — intervention group
Group type: EXPERIMENTAL
Intervention: TT + CTG
Number of subjects: 40
Study 33830339 — intervention group
Group type: COMPARATOR
Intervention: TT + CGF
Number of subjects: 40
Study 35925043 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab in combination with chemotherapy for neoadjuvant treatment and then as a single agent for adjuvant treatment.
Number of subjects: 123
Study 35925043 — intervention group
Group type: COMPARATOR
Intervention: Placebo in combination with chemotherapy for neoadjuvant treatment and then as a single agent for adjuvant treatment.
Number of subjects: 123
Study 33069214 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg once-monthly subcutaneous injection
Number of subjects: 722
Study 33069214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 722
Study 35384714 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk olfactory stimulation (30 seconds before heel stick)
Number of subjects: 48
Study 35384714 — intervention group
Group type: COMPARATOR
Intervention: Control group (heel stick without olfactory stimulation)
Number of subjects: 48
Study 33349135 — intervention group
Group type: EXPERIMENTAL
Intervention: AirSeal
Number of subjects: 100
Study 33349135 — intervention group
Group type: COMPARATOR
Intervention: CIS
Number of subjects: 100
Study 32139488 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral felodipine in patients with coeliac disease (Group A, B+C, D)
Number of subjects: 115
Study 32139488 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral felodipine with grapefruit juice in healthy individuals
Number of subjects: 115
Study 32139488 — intervention group
Group type: COMPARATOR
Intervention: Oral felodipine with water in healthy individuals
Number of subjects: 115
Study 34251506 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir-ritonavir
Number of subjects: 694
Study 34251506 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 694
Study 34251506 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (lopinavir-ritonavir and hydroxychloroquine)
Number of subjects: 694
Study 34251506 — intervention group
Group type: COMPARATOR
Intervention: Control (no antiviral therapy)
Number of subjects: 694
Study 35083335 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensive Interval Training (HIIT)
Number of subjects: 122
Study 33157077 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg subcutaneously every other week
Number of subjects: 364
Study 2006134578 — intervention group
Group type: EXPERIMENTAL
Intervention: Anisodamine 0.5 mg/(kg24 h) intravenously for 7 days
Number of subjects: 38
Study 2006134578 — intervention group
Group type: COMPARATOR
Intervention: Common method (control group)
Number of subjects: 38
Study 2006134578 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 38
Study 35339911 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy (BLT) 10,000 lux
Number of subjects: 30
Study 35339911 — intervention group
Group type: COMPARATOR
Intervention: Placebo (<500 lux)
Number of subjects: 30
Study 33241267 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential anti-tubercular treatment (ATT) regimen
Number of subjects: 97
Study 32911505 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased perceived intrinsic cost of lying (treatment condition)
Number of subjects: 225
Study 32911505 — intervention group
Group type: COMPARATOR
Intervention: Standard condition (control)
Number of subjects: 225
Study 35914303 — intervention group
Group type: COMPARATOR
Intervention: 0.05% cyclosporine eye drops (C group)
Number of subjects: 60
Study 35914303 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (S group)
Number of subjects: 60
Study 35914303 — intervention group
Group type: COMPARATOR
Intervention: Combination of 0.05% cyclosporine and artificial tears (CS group)
Number of subjects: 60
Study 33721454 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPS (oral S‐1 + intravenous and intraperitoneal chemotherapy with paclitaxel)
Number of subjects: 80
Study 33721454 — intervention group
Group type: COMPARATOR
Intervention: Control (oral S‐1 + intravenous chemotherapy with oxaliplatin)
Number of subjects: 80
Study 33721454 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPS (after chemotherapy)
Number of subjects: 80
Study 33721454 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPS and Control (postoperative complications)
Number of subjects: 80
Study 33721454 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPS and Control (follow-up)
Number of subjects: 80
Study 33565403 — intervention group
Group type: EXPERIMENTAL
Intervention: Model group (n = 1,074)
Number of subjects: 1326
Study 33565403 — intervention group
Group type: COMPARATOR
Intervention: Verification group (n = 252)
Number of subjects: 1326
Study 32086925 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon nanoparticles suspension injected into the thyroid gland of trial group patients.
Number of subjects: 64
Study 32086925 — intervention group
Group type: EXPERIMENTAL
Intervention: Total thyroidectomy plus bilateral central neck dissection in trial group.
Number of subjects: 64
Study 32086925 — intervention group
Group type: COMPARATOR
Intervention: Total thyroidectomy plus bilateral central neck dissection in control group.
Number of subjects: 64
Study 32086925 — intervention group
Group type: COMPARATOR
Intervention: Trial group vs Control group for lymph nodes in black-stained tissue.
Number of subjects: 64
Study 32086925 — intervention group
Group type: COMPARATOR
Intervention: Trial group vs Control group for mis-cut parathyroid glands.
Number of subjects: 64
Study 32086925 — intervention group
Group type: COMPARATOR
Intervention: Trial group vs Control group for temporary hypocalcemia.
Number of subjects: 64
Study 32086925 — intervention group
Group type: COMPARATOR
Intervention: Trial group vs Control group for temporary PTH decrease.
Number of subjects: 64
Study 34233779 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPOWER intervention (cognitive-behavioral, acceptance-based), 6 modules totaling 1.5-2 hours.
Number of subjects: 15
Study 32741216 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating serum exosomal miR-20b-5p
Number of subjects: 0
Study 32741216 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating serum exosomal miR-3187-5p
Number of subjects: 0
Study 36322270 — intervention group
Group type: EXPERIMENTAL
Intervention: FIND intervention
Number of subjects: 91
Study 36322270 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 91
Study 33276225 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined (neck stabilization exercises + motor imagery training)
Number of subjects: 72
Study 33276225 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck stabilization exercises alone
Number of subjects: 72
Study 33276225 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 36347535 — intervention group
Group type: EXPERIMENTAL
Intervention: High-efficiency (tiered) OR
Number of subjects: 0
Study 36347535 — intervention group
Group type: COMPARATOR
Intervention: Conventional OR
Number of subjects: 0
Study 32593895 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB-enriched formula (calcium-HMB 1500 mg, L-arginine 7000 mg, L-glutamine 7000 mg per pack, 2 packs per day)
Number of subjects: 33
Study 32593895 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HMB-enriched formula)
Number of subjects: 33
Study 34353714 — intervention group
Group type: EXPERIMENTAL
Intervention: Riociguat
Number of subjects: 579
Study 34353714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 579
Study 32476468 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective indices of estimated degree of relative decline
Number of subjects: 0
Study 32476468 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective measures (Neurobehavioral Symptom Inventory, Personality Assessment Inventory)
Number of subjects: 0
Study 33319565 — intervention group
Group type: EXPERIMENTAL
Intervention: SMOFlipid®
Number of subjects: 73
Study 32171323 — intervention group
Group type: EXPERIMENTAL
Intervention: SGQR formula and buspirone placebo
Number of subjects: 200
Study 32171323 — intervention group
Group type: COMPARATOR
Intervention: Buspirone and SGQR placebo
Number of subjects: 200
Study 33499843 — intervention group
Group type: EXPERIMENTAL
Intervention: 4DryField® PH (5 g, subfascially and subcutaneously during wound closure)
Number of subjects: 40
Study 33499843 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 40
Study 36065678 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser therapy
Number of subjects: 30
Study 36065678 — intervention group
Group type: COMPARATOR
Intervention: Carboxytherapy
Number of subjects: 30
Study 33038944 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1800
Study 33038944 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1800
Study 34789504 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) insulin delivery during high-intensity exercise (HIE)
Number of subjects: 30
Study 34789504 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) insulin delivery during moderate-intensity exercise (MIE)
Number of subjects: 30
Study 34789504 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) insulin delivery during resistance exercise (RE)
Number of subjects: 30
Study 33746986 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis, BB-12)
Number of subjects: 30
Study 33746986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32928851 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythm and Movement for Self-Regulation (RAMSR) intervention delivered by trained teachers during group time in kindergartens, daily for 8 weeks.
Number of subjects: 237
Study 32928851 — intervention group
Group type: COMPARATOR
Intervention: Usual practice kindergarten programme (Control).
Number of subjects: 237
Study 34990037 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2649
Study 34217600 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 Hz-rTMS
Number of subjects: 46
Study 34217600 — intervention group
Group type: COMPARATOR
Intervention: iTBS
Number of subjects: 46
Study 34498352 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week multimodal exercise-based program including supervised exercise twice weekly, protein supplement, home-based walking program, nurse-led support and counseling
Number of subjects: 84
Study 34498352 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week multimodal exercise-based program
Number of subjects: 84
Study 34498352 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 84
Study 34467810 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional education session (working together interprofessionally)
Number of subjects: 225
Study 34467810 — intervention group
Group type: COMPARATOR
Intervention: Control group (working together with their own profession)
Number of subjects: 225
Study 32275482 — intervention group
Group type: EXPERIMENTAL
Intervention: Room temperature
Number of subjects: 95
Study 32275482 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 °C
Number of subjects: 95
Study 32275482 — intervention group
Group type: EXPERIMENTAL
Intervention: ‐80 °C
Number of subjects: 95
Study 32275482 — intervention group
Group type: COMPARATOR
Intervention: Storage temperature
Number of subjects: 95
Study 33555314 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid-tapering regimen (immediate high-dose daily administration of prednisone, 0.75 mg/kg, followed by rapid decrease)
Number of subjects: 117
Study 33555314 — intervention group
Group type: COMPARATOR
Intervention: Slow-tapering regimen (gradual increase to 1.5 mg/kg every other day and slow decrease)
Number of subjects: 117
Study 33555314 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid-tapering regimen
Number of subjects: 117
Study 33555314 — intervention group
Group type: COMPARATOR
Intervention: Slow-tapering regimen
Number of subjects: 117
Study 34346729 — intervention group
Group type: EXPERIMENTAL
Intervention: NIATx1 (active implementation strategy)
Number of subjects: 49
Study 34346729 — intervention group
Group type: COMPARATOR
Intervention: NIATx2 (waitlist control)
Number of subjects: 49
Study 34112615 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 2555
Study 34112615 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 2555
Study 34112615 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery in KRAS/BRAF WT sub-group
Number of subjects: 2555
Study 34112615 — intervention group
Group type: COMPARATOR
Intervention: Open surgery in KRAS/BRAF WT sub-group
Number of subjects: 2555
Study 32311455 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (aqueous solution or suspension)
Number of subjects: 8
Study 32311455 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol (aqueous suspension)
Number of subjects: 8
Study 32311455 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-chain triglyceride solution of danazol
Number of subjects: 8
Study 36189651 — intervention group
Group type: EXPERIMENTAL
Intervention: Polynucleotide and hyaluronic acid-based gel
Number of subjects: 50
Study 33976420 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical genome sequencing (cGS)
Number of subjects: 204
Study 33976420 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care genetic testing (SOC)
Number of subjects: 204
Study 34479364 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants (DOACs) such as apixaban, edoxaban, and rivaroxaban
Number of subjects: 0
Study 34479364 — intervention group
Group type: COMPARATOR
Intervention: Low-molecular-weight heparins (LMWHs) such as dalteparin
Number of subjects: 0
Study 33901518 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher gestational age (per week)
Number of subjects: 421
Study 33901518 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher birthweight (per 100 grams)
Number of subjects: 421
Study 33901518 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher birthweight for gestational age z-score (per SD)
Number of subjects: 421
Study 33901518 — intervention group
Group type: EXPERIMENTAL
Intervention: Birthweight and birthweight for gestational age z-score
Number of subjects: 421
Study 33901518 — intervention group
Group type: EXPERIMENTAL
Intervention: Low birthweight (<2500 g)
Number of subjects: 421